======= TBC1D22B ======= == Gene Information == * **Official Symbol**: TBC1D22B * **Official Name**: TBC1 domain family member 22B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55633|55633]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NU19|Q9NU19]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TBC1D22B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TBC1D22B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616880|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |TBC| |14-3-3 protein binding| |regulation of cilium assembly| |cell| |activation of GTPase activity| |Rab GTPase binding| |regulation of plasma membrane bounded cell projection assembly| |regulation of cell projection assembly| |regulation of organelle assembly| |GTPase activator activity| |positive regulation of GTPase activity| |regulation of GTPase activity| |regulation of plasma membrane bounded cell projection organization| |regulation of cell projection organization| |positive regulation of hydrolase activity| |regulation of cellular component biogenesis| |intracellular protein transport| |regulation of hydrolase activity| |regulation of organelle organization| |positive regulation of catalytic activity| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |positive regulation of molecular function| |establishment of localization in cell| |nitrogen compound transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-4.08| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-3.37| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-3.12| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|-2.06| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.83| |[[:results:exp169|BH1 1μM R04 exp169]]|-1.72| |[[:results:exp447|Amiloride 100μM R08 exp447]]|1.75| ^Gene^Correlation^ |[[:human genes:c:cog5|COG5]]|0.436| |[[:human genes:g:gpr107|GPR107]]|0.421| |[[:human genes:a:apba3|APBA3]]|0.42| |[[:human genes:s:slc39a9|SLC39A9]]|0.412| |[[:human genes:t:tbc1d23|TBC1D23]]|0.406| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8613 * **Expression level (log2 read counts)**: 3.95 {{:chemogenomics:nalm6 dist.png?nolink |}}